ABVX – Abivax ADR

ABVX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.16

Margin Of Safety %

Put/Call OI Ratio

0.49

EPS Next Q Diff

EPS Last/This Y

1.8

EPS This/Next Y

0.39

Price

97.4

Target Price

143.51

Analyst Recom

1.39

Performance Q

-10.94

Upside

-170.0%

Beta

1.38

Ticker: ABVX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-29	ABVX	132.94	0.56	0.36	97472
2026-06-02	ABVX	72.77	0.56	0.69	89345
2026-06-03	ABVX	90.15	0.46	0.34	110798
2026-06-04	ABVX	103.86	0.42	0.48	136742
2026-06-05	ABVX	101.63	0.43	0.45	144677
2026-06-08	ABVX	101.35	0.44	1.54	129468
2026-06-09	ABVX	102.67	0.53	0.55	139299
2026-06-10	ABVX	98.09	0.54	0.43	141976
2026-06-11	ABVX	100.79	0.54	0.41	145553
2026-06-12	ABVX	96.58	0.53	0.35	149511
2026-06-15	ABVX	98.4	0.50	0.47	147150
2026-06-16	ABVX	97.48	0.51	0.54	161021
2026-06-17	ABVX	100.1	0.51	0.62	167800
2026-06-18	ABVX	99.01	0.53	1.03	186243
2026-06-22	ABVX	101.74	0.51	0.30	161486
2026-06-23	ABVX	98.49	0.49	0.52	176278
2026-06-24	ABVX	92.52	0.48	0.50	181936
2026-06-25	ABVX	92.33	0.49	0.75	197345
2026-06-26	ABVX	97.46	0.49	0.59	206213
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-29	ABVX	132.76	17.2	-	-4.20
2026-06-01	ABVX	129.54	24.5	-	-3.45
2026-06-02	ABVX	72.56	24.5	-	-3.45
2026-06-03	ABVX	90.14	30.6	-	-3.34
2026-06-04	ABVX	105.04	30.6	-	-3.34
2026-06-05	ABVX	101.55	30.6	-	-3.54
2026-06-08	ABVX	101.46	26.6	-	-3.54
2026-06-09	ABVX	102.65	26.6	-	-3.60
2026-06-10	ABVX	98.06	26.6	-	-3.60
2026-06-11	ABVX	100.79	26.6	-	-3.60
2026-06-12	ABVX	96.56	26.6	-	-3.60
2026-06-15	ABVX	98.34	26.6	-	-3.60
2026-06-16	ABVX	97.50	26.6	-	-3.60
2026-06-17	ABVX	100.09	26.6	-	-3.60
2026-06-18	ABVX	99.03	26.6	-	-3.60
2026-06-22	ABVX	101.70	26.7	-	-3.60
2026-06-23	ABVX	98.48	26.7	-	-3.60
2026-06-24	ABVX	92.60	26.7	-	-3.60
2026-06-25	ABVX	92.36	26.7	-	-3.60
2026-06-26	ABVX	97.40	-1.8	-	-3.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-29	ABVX	0.00	-7.04	3.64
2026-06-02	ABVX	0.00	-6.81	3.64
2026-06-03	ABVX	0.00	-6.81	3.64
2026-06-04	ABVX	0.00	-6.81	3.64
2026-06-05	ABVX	0.00	-6.81	3.64
2026-06-08	ABVX	0.00	-7.24	3.64
2026-06-09	ABVX	0.00	-7.24	3.64
2026-06-10	ABVX	0.00	-7.24	4.48
2026-06-11	ABVX	0.00	-7.24	4.48
2026-06-12	ABVX	0.00	-7.24	4.48
2026-06-15	ABVX	0.00	-1.50	4.47
2026-06-16	ABVX	0.00	-1.50	4.47
2026-06-17	ABVX	0.00	-1.50	4.47
2026-06-18	ABVX	0.00	-1.50	4.47
2026-06-22	ABVX	0.00	-1.63	4.47
2026-06-23	ABVX	0.00	-1.63	4.47
2026-06-24	ABVX	0.00	-1.63	4.47
2026-06-25	ABVX	0.00	-1.63	4.47
2026-06-26	ABVX	0.00	-1.63	7.16
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.71

Avg. EPS Est. Current Quarter

-0.91

Avg. EPS Est. Next Quarter

-0.71

Insider Transactions

Institutional Transactions

-1.63

Beta

1.38

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

34.6

Max Drawdown 5-Year %

Target Price

143.51

P/E

Forward P/E

PEG

P/S

P/B

15.62

P/Free Cash Flow

EPS

-5.25

Average EPS Est. Cur. Y

-3.69

EPS Next Y. (Est.)

-3.3

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.95

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-88.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

0.51

EBIT Estimation

◆ ABVX Healthcare

$97.50

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

13/25

Volume

7/15

Valuation

10/20

TP/AR

2/10

Options

5/10

RSI

44.6

Range 1M

43.6%

Sup Dist

9.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

16/30

Estimates

0/20

Inst/Vol

2/15

Options

5/10

EPS Yr

47.2%

EPS NY

-20.9%

52W%

64.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +47.2% upside

Quality

2/30

Valuation

10/30

Growth

12/25

Stability

6/10

LT Trend

0/5

Upside

+47.2%

Quality

ABVX — P/E HistoricalBiotechnology

Abivax SA

Sector: Healthcare

Industry: Biotechnology

Employees: 80

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

ABVX

Latest News

—

Caricamento notizie per ABVX…

stock quote shares ABVX – Abivax ADR Stock Price stock today

news today ABVX – Abivax ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch ABVX – Abivax ADR yahoo finance google finance

stock history ABVX – Abivax ADR invest stock market

stock prices ABVX premarket after hours

ticker ABVX fair value insiders trading

SNY – Sanofi

SNY — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.27

Margin Of Safety %

Put/Call OI Ratio

0.9

EPS Next Q Diff

0.55

EPS Last/This Y

1.34

EPS This/Next Y

0.31

Price

42.96

Target Price

53.92

Analyst Recom

2.29

Performance Q

-7.87

Upside

-27.7%

Beta

0.32

Ticker: SNY

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-29	SNY	43.68	1.02	0.37	62513
2026-06-02	SNY	42.81	1.02	1.56	63714
2026-06-03	SNY	42.38	1.03	2.34	64173
2026-06-04	SNY	44.38	1.03	0.31	64594
2026-06-05	SNY	45.02	1.03	0.80	65129
2026-06-08	SNY	43.88	1.03	2.01	65814
2026-06-09	SNY	44.71	1.05	0.52	66854
2026-06-10	SNY	43.56	1.05	0.52	67312
2026-06-11	SNY	44.13	1.05	1.19	67625
2026-06-12	SNY	44.26	1.05	0.53	68361
2026-06-15	SNY	43.81	1.04	0.81	68635
2026-06-16	SNY	44.06	1.05	0.19	69710
2026-06-17	SNY	42.53	1.00	0.29	71832
2026-06-18	SNY	42.39	0.95	0.11	70640
2026-06-22	SNY	41.8	0.95	0.15	62939
2026-06-23	SNY	41.63	0.92	0.50	64564
2026-06-24	SNY	41.33	0.90	1.62	65773
2026-06-25	SNY	41.8	0.89	0.93	66893
2026-06-26	SNY	42.97	0.90	1.08	68442
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-29	SNY	43.69	24.3	4228.9	4.81
2026-06-01	SNY	42.98	24.3	4216.1	4.81
2026-06-02	SNY	42.76	24.3	4329.3	4.81
2026-06-03	SNY	42.38	24.3	4330.3	4.95
2026-06-04	SNY	44.38	24.3	4925.0	4.95
2026-06-05	SNY	45.01	24.3	4180.2	4.95
2026-06-08	SNY	43.88	24.3	4105.2	4.98
2026-06-09	SNY	44.70	24.3	4698.2	4.98
2026-06-10	SNY	43.54	24.3	4372.3	4.98
2026-06-11	SNY	44.14	24.3	4656.8	4.98
2026-06-12	SNY	44.25	24.3	4643.0	4.98
2026-06-15	SNY	43.81	24.3	4496.6	4.98
2026-06-16	SNY	44.05	24.3	4700.7	4.98
2026-06-17	SNY	42.50	24.3	4036.4	4.98
2026-06-18	SNY	42.40	24.3	4117.0	4.98
2026-06-22	SNY	41.79	24.3	4174.9	4.98
2026-06-23	SNY	41.60	24.3	4247.0	4.98
2026-06-24	SNY	41.33	24.3	4046.0	4.98
2026-06-25	SNY	41.80	24.3	4232.6	4.98
2026-06-26	SNY	42.96	24.3	4557.5	4.98
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-29	SNY	0	-0.37	0
2026-06-02	SNY	0	-2.25	0.27
2026-06-03	SNY	0	-2.25	0.27
2026-06-04	SNY	0	-2.25	0.27
2026-06-05	SNY	0	-2.25	0.27
2026-06-08	SNY	0	-2.23	0.27
2026-06-09	SNY	0	-2.23	0.27
2026-06-10	SNY	0	-2.23	0.28
2026-06-11	SNY	0	-2.23	0.28
2026-06-12	SNY	0	-2.23	0.28
2026-06-15	SNY	0	-2.23	0.28
2026-06-16	SNY	0	-2.23	0.28
2026-06-17	SNY	0	-2.23	0.28
2026-06-18	SNY	0	-2.23	0.28
2026-06-22	SNY	0	-2.19	0.28
2026-06-23	SNY	0	-2.19	0.28
2026-06-24	SNY	0	-2.19	0.28
2026-06-25	SNY	0	-2.19	0.28
2026-06-26	SNY	0	-2.19	0.27
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

1.1

Avg. EPS Est. Current Quarter

1.13

Avg. EPS Est. Next Quarter

1.65

Insider Transactions

Institutional Transactions

-2.19

Beta

0.32

Average Sales Estimate Current Quarter

10997

Average Sales Estimate Next Quarter

13457

Fair Value

56.79

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

28.5

Max Drawdown 5-Year %

-33.5

Target Price

53.92

P/E

17.99

Forward P/E

8.08

PEG

1.11

P/S

2.09

P/B

1.24

P/Free Cash Flow

9.85

EPS

2.39

Average EPS Est. Cur. Y

4.98

EPS Next Y. (Est.)

5.29

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.81

Relative Volume

2.22

Return on Equity vs Sector %

-22.1

Return on Equity vs Industry %

-32.8

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.17

EBIT Estimation

4557.5

◆ SNY Healthcare

$42.95

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

17/25

Volume

3/15

Valuation

18/20

TP/AR

1/10

Options

4/10

RSI

47.8

Range 1M

34.5%

Sup Dist

3.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

10/30

Estimates

5/20

Inst/Vol

3/15

Options

2/10

EPS Yr

6.7%

EPS NY

6.6%

52W%

12.7%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +44.8% upside

Quality

14/30

Valuation

20/30

Growth

8/25

Stability

3/10

LT Trend

1/5

Upside

+44.8%

Quality

MoS

32%

SNY — P/E HistoricalDrug Manufacturers - General

Sanofi

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 74846

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

SNY

Latest News

—

Caricamento notizie per SNY…

stock quote shares SNY – Sanofi Stock Price stock today

news today SNY – Sanofi stock forecast ,stock prediction 2023 2024 2025

marketwatch SNY – Sanofi yahoo finance google finance

stock history SNY – Sanofi invest stock market

stock prices SNY premarket after hours

ticker SNY fair value insiders trading

TTE – Total Energies SE

TTE — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.21

Margin Of Safety %

Put/Call OI Ratio

0.84

EPS Next Q Diff

0.41

EPS Last/This Y

5.58

EPS This/Next Y

-1.48

Price

76.61

Target Price

98.55

Analyst Recom

1.78

Performance Q

-14.65

Upside

16.8%

Beta

0.18

Ticker: TTE

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-29	TTE	87.38	0.81	0.07	75612
2026-06-02	TTE	89.46	0.77	0.27	77564
2026-06-03	TTE	89.55	0.76	0.61	78997
2026-06-04	TTE	90.15	0.76	2.45	79134
2026-06-05	TTE	88.73	0.76	0.67	79234
2026-06-08	TTE	88.6	0.76	0.55	79132
2026-06-09	TTE	88.47	0.76	0.41	79070
2026-06-10	TTE	88.45	0.76	0.97	79105
2026-06-11	TTE	87.61	0.76	0.18	79218
2026-06-12	TTE	88	0.75	0.79	78559
2026-06-15	TTE	84.11	0.75	0.45	78460
2026-06-16	TTE	84.17	0.74	0.08	78235
2026-06-17	TTE	82.19	0.74	0.43	77601
2026-06-18	TTE	80.47	0.72	1.15	77290
2026-06-22	TTE	80.7	0.96	0.04	53402
2026-06-23	TTE	80.4	0.86	0.60	56653
2026-06-24	TTE	78.7	0.86	0.19	56631
2026-06-25	TTE	78.26	0.84	0.64	57374
2026-06-26	TTE	76.77	0.84	1.40	58107
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-29	TTE	87.29	-	6978.0	11.45
2026-06-01	TTE	88.75	-	7774.6	11.45
2026-06-02	TTE	89.46	-	7525.8	11.45
2026-06-03	TTE	89.56	-	7167.3	11.45
2026-06-04	TTE	90.14	-	7306.3	11.45
2026-06-05	TTE	88.73	-	6612.3	11.45
2026-06-08	TTE	88.59	-	7342.7	11.45
2026-06-09	TTE	88.47	-	7303.8	11.45
2026-06-10	TTE	88.41	-	7675.9	11.45
2026-06-11	TTE	87.69	-	7135.9	11.45
2026-06-12	TTE	88.06	-	7003.9	11.45
2026-06-15	TTE	84.16	-	6335.8	11.45
2026-06-16	TTE	84.18	-	7483.9	11.45
2026-06-17	TTE	82.15	-	6742.7	11.45
2026-06-18	TTE	80.43	-	7241.2	11.45
2026-06-22	TTE	80.76	-	8114.5	11.45
2026-06-23	TTE	80.31	-	7713.3	11.45
2026-06-24	TTE	78.70	-	7160.9	11.45
2026-06-25	TTE	78.27	-	7602.7	11.45
2026-06-26	TTE	76.61	-	7047.2	11.42
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-29	TTE	0.00	15.34	0.20
2026-06-02	TTE	0.00	13.30	0.20
2026-06-03	TTE	0.00	13.30	0.20
2026-06-04	TTE	0.00	13.30	0.20
2026-06-05	TTE	0.00	13.30	0.20
2026-06-08	TTE	0.00	13.11	0.20
2026-06-09	TTE	0.00	13.11	0.20
2026-06-10	TTE	0.00	13.11	0.21
2026-06-11	TTE	0.00	13.11	0.21
2026-06-12	TTE	0.00	13.11	0.21
2026-06-15	TTE	0.00	7.05	0.21
2026-06-16	TTE	0.00	7.05	0.21
2026-06-17	TTE	0.00	7.05	0.21
2026-06-18	TTE	0.00	7.05	0.21
2026-06-22	TTE	0.00	7.01	0.21
2026-06-23	TTE	0.00	7.01	0.21
2026-06-24	TTE	0.00	7.01	0.21
2026-06-25	TTE	0.00	7.01	0.21
2026-06-26	TTE	0.00	7.01	0.21
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

2.45

Avg. EPS Est. Current Quarter

2.84

Avg. EPS Est. Next Quarter

2.86

Insider Transactions

Institutional Transactions

7.01

Beta

0.18

Average Sales Estimate Current Quarter

52436

Average Sales Estimate Next Quarter

50267

Fair Value

98.71

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

18.7

Max Drawdown 5-Year %

-26.3

Target Price

98.55

P/E

11.12

Forward P/E

7.98

PEG

0.73

P/S

0.93

P/B

1.34

P/Free Cash Flow

15.34

EPS

6.9

Average EPS Est. Cur. Y

11.42

EPS Next Y. (Est.)

9.94

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.2

Relative Volume

1.67

Return on Equity vs Sector %

Return on Equity vs Industry %

2.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

7047.2

◆ TTE Energy

$76.77

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

18/20

Pullback

5/25

Volume

3/15

Valuation

18/20

TP/AR

5/10

Options

2/10

RSI

Range 1M

🚀

Momentum Growth

Ride accelerating trends

N/A

WATCH

Momentum

17/25

Growth

20/30

Estimates

8/20

Inst/Vol

9/15

Options

4/10

EPS Yr

58.2%

EPS NY

-11.8%

52W%

52.9%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +48.4% upside

Quality

8/30

Valuation

22/30

Growth

15/25

Stability

4/10

LT Trend

1/5

Upside

+48.4%

Quality

MoS

29%

TTE — P/E HistoricalOil & Gas Integrated

TotalEnergies SE

Sector: Energy

Industry: Oil & Gas Integrated

Employees: 94847

TotalEnergies SE, an integrated energy company, produces and markets oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables, and electricity in France, the United States, Europe, Brazil, India, and internationally. The company was formerly known as TOTAL SE and changed its name to TotalEnergies SE in June 2021. TotalEnergies SE was incorporated in 1924 and is headquartered in Courbevoie, France.

TTE

Latest News

—

Caricamento notizie per TTE…

stock quote shares TTE – Total Energies SE Stock Price stock today

news today TTE – Total Energies SE stock forecast ,stock prediction 2023 2024 2025

marketwatch TTE – Total Energies SE yahoo finance google finance

stock history TTE – Total Energies SE invest stock market

stock prices TTE premarket after hours

ticker TTE fair value insiders trading

CSTM – Constellium SE

CSTM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.86

Margin Of Safety %

Put/Call OI Ratio

0.45

EPS Next Q Diff

-0.46

EPS Last/This Y

1.03

EPS This/Next Y

-0.45

Price

31.8

Target Price

38.2

Analyst Recom

1.4

Performance Q

32.69

Upside

26.8%

Beta

1.54

Ticker: CSTM

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-29	CSTM	34.29	0.45	0.32	28755
2026-06-02	CSTM	36.08	0.44	1.14	29081
2026-06-03	CSTM	35.86	0.45	0.06	30003
2026-06-04	CSTM	36.14	0.47	1.09	29210
2026-06-05	CSTM	33.89	0.48	0.74	29336
2026-06-08	CSTM	34.19	0.48	0.25	29396
2026-06-09	CSTM	33.98	0.48	0.19	29393
2026-06-10	CSTM	32.64	0.49	0.24	29362
2026-06-11	CSTM	34.76	0.48	0.24	29776
2026-06-12	CSTM	35.59	0.48	1.65	29848
2026-06-15	CSTM	34.71	0.48	0.21	29874
2026-06-16	CSTM	34.2	0.48	1.27	30081
2026-06-17	CSTM	33.69	0.48	0.55	30151
2026-06-18	CSTM	34.01	0.48	0.82	30237
2026-06-22	CSTM	34.58	0.46	0.25	27665
2026-06-23	CSTM	33.26	0.45	0.44	28367
2026-06-24	CSTM	32.64	0.45	6.26	28567
2026-06-25	CSTM	33.72	0.45	0.22	28637
2026-06-26	CSTM	31.78	0.45	0.31	28794
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-29	CSTM	34.29	843.4	-	3.02
2026-06-01	CSTM	34.69	843.4	-	3.02
2026-06-02	CSTM	36.20	843.4	-	3.02
2026-06-03	CSTM	35.89	843.4	-	2.98
2026-06-04	CSTM	36.13	843.4	-	2.98
2026-06-05	CSTM	33.90	843.4	-	2.98
2026-06-08	CSTM	34.18	843.4	-	2.98
2026-06-09	CSTM	34.00	843.4	-	2.98
2026-06-10	CSTM	32.65	843.4	-	2.98
2026-06-11	CSTM	34.73	843.4	-	2.98
2026-06-12	CSTM	35.59	843.4	-	2.98
2026-06-15	CSTM	34.72	843.4	-	2.98
2026-06-16	CSTM	34.19	843.4	-	2.98
2026-06-17	CSTM	33.65	843.4	-	2.98
2026-06-18	CSTM	34.02	843.4	-	2.98
2026-06-22	CSTM	34.58	843.4	-	2.98
2026-06-23	CSTM	33.27	843.4	-	2.98
2026-06-24	CSTM	32.65	843.4	-	2.98
2026-06-25	CSTM	33.71	843.4	-	2.98
2026-06-26	CSTM	31.80	843.4	-	2.98
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-29	CSTM	-2.38	-0.41	5.07
2026-06-02	CSTM	-3.25	-0.61	4.90
2026-06-03	CSTM	-3.25	-0.61	4.90
2026-06-04	CSTM	-3.25	-0.61	4.90
2026-06-05	CSTM	-3.26	-0.61	4.90
2026-06-08	CSTM	-3.32	1.02	4.90
2026-06-09	CSTM	-3.32	1.02	4.90
2026-06-10	CSTM	-3.32	1.02	5.05
2026-06-11	CSTM	-3.32	1.02	5.05
2026-06-12	CSTM	-3.32	1.02	5.05
2026-06-15	CSTM	-3.32	0.76	5.05
2026-06-16	CSTM	-3.32	0.76	5.05
2026-06-17	CSTM	-3.32	0.76	5.05
2026-06-18	CSTM	-3.32	0.76	5.05
2026-06-22	CSTM	-3.32	0.76	5.05
2026-06-23	CSTM	-3.30	0.76	5.14
2026-06-24	CSTM	-2.83	0.76	5.14
2026-06-25	CSTM	-2.83	0.76	5.05
2026-06-26	CSTM	-3.32	0.76	4.86
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

1.02

Avg. EPS Est. Current Quarter

0.81

Avg. EPS Est. Next Quarter

0.56

Insider Transactions

-3.32

Institutional Transactions

0.76

Beta

1.54

Average Sales Estimate Current Quarter

2343

Average Sales Estimate Next Quarter

2271

Fair Value

32.08

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-66.3

Target Price

38.2

P/E

10.26

Forward P/E

11.6

PEG

0.35

P/S

0.48

P/B

3.87

P/Free Cash Flow

24.59

EPS

3.1

Average EPS Est. Cur. Y

2.98

EPS Next Y. (Est.)

2.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.87

Relative Volume

2.97

Return on Equity vs Sector %

22.7

Return on Equity vs Industry %

25.6

EPS 1 7Days Diff

1.2

EPS 1 30Days Diff

1.29

EBIT Estimation

◆ CSTM Basic Materials

$31.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

16/25

Volume

3/15

Valuation

15/20

TP/AR

6/10

Options

6/10

RSI

42.7

Range 1M

11.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WATCH

Momentum

5/25

Growth

23/30

Estimates

9/20

Inst/Vol

10/15

Options

9/10

EPS Yr

171%

EPS NY

-18.3%

52W%

76.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +6.1% upside

Quality

13/30

Valuation

9/30

Growth

18/25

Stability

3/10

LT Trend

0/5

Upside

+6.1%

Quality

MoS

CSTM — P/E HistoricalAluminum

Constellium SE

Sector: Basic Materials

Industry: Aluminum

Employees: 11500

Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the aerospace, packaging, automotive, commercial transportation, general industrial, and defense end-markets. It operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry. The Packaging & Automotive Rolled Products segment produces and develops rolled aluminum products, including canstock and closure stock for the beverage and food industry, as well as foil stock for the flexible packaging market. This segment also supplies automotive body sheets, heat exchangers, and battery foil products for the automotive market. The Aerospace & Transportation segment provides aluminum products including plate, sheet, and extrusions to aerospace, space, commercial transportation, general industrial, and defense sectors. The Automotive Structures & Industry segment offers structural solutions for the automotive industry including crash management systems, body structures, side impact beams, and battery enclosure components; soft and hard alloy extrusions for automotive, transportation, and general industrial applications; and profiles for rail and general industrial applications. This segment also provides downstream technology and services, which include pre-machining, surface treatment, research and development, and technical support services. It sells its products directly or through distributors in France, Germany, the Czech Republic, the United Kingdom, Switzerland, and the United States, as well as South Korea, Japan and China. The company was incorporated in 2010 and is headquartered in Paris, France.

CSTM

Latest News

—

Caricamento notizie per CSTM…

stock quote shares CSTM – Constellium SE Stock Price stock today

news today CSTM – Constellium SE stock forecast ,stock prediction 2023 2024 2025

marketwatch CSTM – Constellium SE yahoo finance google finance

stock history CSTM – Constellium SE invest stock market

stock prices CSTM premarket after hours

ticker CSTM fair value insiders trading

ABVX – Abivax ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABVX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

SNY – Sanofi

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SNY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y